Ahmedashry (Talk | contribs) |
Ahmedashry (Talk | contribs) |
||
Line 99: | Line 99: | ||
<body> | <body> | ||
<section class="header" id="header"> | <section class="header" id="header"> | ||
− | |||
<nav class="navbar navbar-default navbar-fixed-top"> | <nav class="navbar navbar-default navbar-fixed-top"> | ||
<div class="container"> | <div class="container"> | ||
Line 185: | Line 184: | ||
<div class="container section-wrapper"> | <div class="container section-wrapper"> | ||
<h3 class='text-center' style='margin-bottom:30px'>Abstract</h3> | <h3 class='text-center' style='margin-bottom:30px'>Abstract</h3> | ||
− | <h3> | + | <h3>Competing endogenous RNA network : Potential entrants to gene editing in Hepatocellular Carcinoma </h4> |
<div> | <div> |
Revision as of 14:04, 21 October 2017
Abstract
Competing endogenous RNA network : Potential entrants to gene editing in Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers
in males and next to breast cancer among females in Egypt - based upon results of National Cancer Registry Program of Egypt-.
"Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique
that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma.
This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials.
This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.
Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers in males and next to breast cancer among females in Egypt - based upon results of National Cancer Registry Program of Egypt-. "Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma. This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials. This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.